Latest Catecholamines Stories
Continuous levodopa therapy with ND0612H has the potential to prevent or delay the need for surgical intervention in patients with severe stage Parkinson's disease REHOVOT, Israel, September
REHOVOT, Israel, August 21, 2014 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ] Ltd., a clinical stage pharmaceutical company developing drugs for central nervous
REHOVOT, Israel, August 4, 2014 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ] Ltd.
Dysfunction in dopamine signaling profoundly changes the activity level of about 2,000 genes in the brain’s prefrontal cortex and may be an underlying cause of certain complex neuropsychiatric disorders, such as schizophrenia, according to UC Irvine scientists.
New TAU study confirms creative energy in Parkinson's sufferers is greater than in healthy individuals
NEW YORK, June 18, 2014 /PRNewswire-USNewswire/ -- With long-term use, the gold standard medication for Parkinson's disease, levodopa, can wear off before it's time for another dose, causing
LONDON, June 18, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
EMERYVILLE, Calif., June 10, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., June 9, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc.
EMERYVILLE, Calif., May 29, 2014 /PRNewswire/ -- Adamas Pharmaceuticals, Inc.
- totally perplexed and mixed up.